Search - tctmd.com

Displaying 261 - 280 of 1806

Sort: Relevancy | Date

Presentation TVT 2023

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Presenter: Michael Mack

June 08, 2023

Presentation TVT 2023

Results From TAVR Explanation and Redo SAVR are Important Considerations: Updates and Evidence Gaps

Presenter: Basel Ramlawi

June 08, 2023

Presentation TVT 2023

Counterpoint: Not Ready Yet – Ensuring Reproducible ‘Surgical-Like’ Results Needs to be Demonstrated First!

Presenter: Thomas Modine

June 08, 2023

Presentation TVT 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Presenter: Danny Dvir

June 08, 2023

Presentation TVT 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presenter: Firas Zahr

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: Planning for the 2nd Valve Before Placing the First One: Anatomic Considerations in Treating Patients With Long Life Expectancy

Presenter: Janarthanan Sathananthan

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: TEER in Primary MR - Clinical Evidence, Indications, and Controversies

Presenter: Charles Davidson

June 08, 2023

Presentation TVT 2023

How Do We Communicate Known vs Uncertain Risks and Benefits of TAVR to Younger (<65 yo) Patients?

Presenter: Sammy Elmariah

June 08, 2023

Presentation TVT 2023

Putting “Lifetime” Into Perspective (How Long Do Patients With AS / AVR Actually Survive)

Presenter: Michael Mack

June 08, 2023

News Conference News EHRA 2023

EPs Push for More Involvement in TAVI Heart Team Discussions

Michael O'Riordan

April 21, 2023

News Daily News

Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest

Caitlin E. Cox

April 11, 2023

News Daily News

AHA Urges Holistic Cardiovascular Care of Women, With Focus on Race/Ethnicity

Yael L. Maxwell

April 10, 2023

News Opinion Fellow Talk

The Evolving Role of Industry and the Interventional Cardiology Fellow

Poornima Mohan, MBChB

March 31, 2023

News Featured Fellow

Daniel Shpilsky, MD

Yael L. Maxwell

March 31, 2023

News Conference News ACC 2023

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

Caitlin E. Cox

March 10, 2023

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

Todd Neale

March 05, 2023

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

Advertisement

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Results From TAVR Explanation and Redo SAVR are Important Considerations: Updates and Evidence Gaps

Counterpoint: Not Ready Yet – Ensuring Reproducible ‘Surgical-Like’ Results Needs to be Demonstrated First!

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

SPOTLIGHT LECTURE: Planning for the 2nd Valve Before Placing the First One: Anatomic Considerations in Treating Patients With Long Life Expectancy

SPOTLIGHT LECTURE: TEER in Primary MR - Clinical Evidence, Indications, and Controversies

How Do We Communicate Known vs Uncertain Risks and Benefits of TAVR to Younger (<65 yo) Patients?

Putting “Lifetime” Into Perspective (How Long Do Patients With AS / AVR Actually Survive)

EPs Push for More Involvement in TAVI Heart Team Discussions

Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest

AHA Urges Holistic Cardiovascular Care of Women, With Focus on Race/Ethnicity

The Evolving Role of Industry and the Interventional Cardiology Fellow

Daniel Shpilsky, MD

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Only Half of Revascularized PAD Patients Receive GDMT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content